The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Targeting Antibiotic Resistance
Open accessAbstract
Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Transcription factors: from enhancer binding to developmental control
Spitz, F., & Furlong, E. E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3207 · Cited by 2,227
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Nature · doi:10.1038/35030019 · Cited by 1,615
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Recognition of Cognate Transfer RNA by the 30 S Ribosomal Subunit
Ogle, J. M., Brodersen, D. E., Clemons, W. M., Tarry, M. J., Carter, A. P., & Ramakrishnan, V. (2001) · Science · doi:10.1126/science.1060612 · Cited by 1,162
Schatz, A., Bugle, E., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-55-14461 · Cited by 1,150
The TetR Family of Transcriptional Repressors
Ramos, J. L., Martínez-Bueno, M., Molina-Henares, A. J., Terán, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., & Tobes, R. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.326-356.2005 · Cited by 1,103
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
A decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
Schlünzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A., & Franceschi, F. (2001) · Nature · doi:10.1038/35101544 · Cited by 1,059
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950
Ribosome Structure and the Mechanism of Translation
Ramakrishnan, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00619-0 · Cited by 938
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 739
PENICILLIN-BINDING PROTEINS AND THE MECHANISM OF ACTION OF BETA-LACTAM ANTIBIOTICS
Waxman, D. J., & Strominger, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.004141 · Cited by 721
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
The bacterial ribosome as a target for antibiotics
Poehlsgaard, J., & Douthwaite, S. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1265 · Cited by 607
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Brickner, S. J., Hutchinson, D. K., Barbachyn, M. R., Manninen, P. R., Ulanowicz, D. A., Garmon, S. A., Grega, K. C., Hendges, S. K., Toops, D. S., Ford, C. W., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509556 · Cited by 582
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200528 · Cited by 553
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Regulation of gene expression by small molecules
Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E., & Dervan, P. B. (1997) · Nature · doi:10.1038/387202a0 · Cited by 470
The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria
Williams, D. H., & Bardsley, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990503)38:9<1172::aid-anie1172>3.0.co;2-c · Cited by 468
tRNA selection and kinetic proofreading in translation
Blanchard, S. C., Gonzalez, R. L., Kim, H. D., Chu, S., & Puglisi, J. D. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb831 · Cited by 466
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460
Boron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
A structural understanding of the dynamic ribosome machine
Steitz, T. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2352 · Cited by 448
Lim, D., & Strynadka, N. C. J. (2002) · Nature Structural Biology · doi:10.1038/nsb858 · Cited by 442
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Dunkle, J. A., Xiong, L., Mankin, A. S., & Cate, J. H. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007988107 · Cited by 413
Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance
Hinrichs, W., Kisker, C., Düvel, M., Müller, A., Tovar, K., Hillen, W., & Saenger, W. (1994) · Science · doi:10.1126/science.8153629 · Cited by 408
English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., & Barth, W. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.414 · Cited by 404
Oxazolidinones: activity, mode of action, and mechanism of resistance
Bozdogan, B., & Appelbaum, P. C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.003 · Cited by 403
Thaker, M., Spanogiannopoulos, P., & Wright, G. D. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0172-6 · Cited by 378
Insights into the decoding mechanism from recent ribosome structures
Ogle, J. M., Carter, A. P., & Ramakrishnan, V. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00066-5 · Cited by 371
Structural basis for aminoglycoside inhibition of bacterial ribosome recycling
Borovinskaya, M. A., Pai, R. D., Zhang, W., Schuwirth, B. S., Holton, J. M., Hirokawa, G., Kaji, H., Kaji, A., & Cate, J. H. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1271 · Cited by 371
Francois, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki862 · Cited by 343
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Proliferation and significance of clinically relevant β‐lactamases
Bush, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12023 · Cited by 337
The A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
Ippolito, J. A., Kanyo, Z. F., Wang, D., Franceschi, F. J., Moore, P. B., Steitz, T. A., & Duffy, E. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800379d · Cited by 303
Harms, J. M., Wilson, D. N., Schluenzen, F., Connell, S. R., Stachelhaus, T., Zaborowska, Z., Spahn, C. M. T., & Fucini, P. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.01.009 · Cited by 302
Otero, L. H., Rojas-Altuve, A., Llarrull, L. I., Carrasco-López, C., Kumarasiri, M., Lastochkin, E., Fishovitz, J., Dawley, M., Hesek, D., Lee, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300118110 · Cited by 281
SnB: crystal structure determination via shake-and-bake
Miller, R., Gallo, S. M., Khalak, H. G., & Weeks, C. M. (1994) · Journal of Applied Crystallography · doi:10.1107/s0021889894000191 · Cited by 278
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 276
Structural insights into peptide bond formation
Hansen, J. L., Schmeing, T. M., Moore, P. B., & Steitz, T. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172404099 · Cited by 273
Livermore, D. M., Mushtaq, S., Warner, M., Zhang, J., Maharjan, S., Doumith, M., & Woodford, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-10 · Cited by 261
The oxazolidinones: past, present, and future
Shaw, K. J., & Barbachyn, M. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06330.x · Cited by 259
Finlay, A. C., Hobby, G. L., P'an, S. Y., Regna, P. P., Routien, J. B., Seeley, D. B., Shull, G. M., Sobin, B. A., Solomons, I. A., Vinson, J. W., et al. (1950) · Science · doi:10.1126/science.111.2874.85 · Cited by 257
Vicens, Q., & Westhof, E. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00153-9 · Cited by 242
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Coleman, K. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.026 · Cited by 241
MORIMOTO, S., TAKAHASHI, Y., WATANABE, Y., & OMURA, S. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.187 · Cited by 233
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
Schlünzen, F., Harms, J. M., Franceschi, F., Hansen, H. A. S., Bartels, H., Zarivach, R., & Yonath, A. (2003) · Structure · doi:10.1016/s0969-2126(03)00022-4 · Cited by 231
Lahiri, S. D., Mangani, S., Durand-Reville, T., Benvenuti, M., De Luca, F., Sanyal, G., & Docquier, J.-D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02247-12 · Cited by 230
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Kisker, C., Hinrichs, W., Tovar, K., Hillen, W., & Saenger, W. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0138 · Cited by 225
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Jenner, L., Starosta, A. L., Terry, D. S., Mikolajka, A., Filonava, L., Yusupov, M., Blanchard, S. C., Wilson, D. N., & Yusupova, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216691110 · Cited by 204
Crystal structure of vancomycin
Schäfer, M., Schneider, T. R., & Sheldrick, G. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00156-6 · Cited by 203
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., Walkty, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.25 · Cited by 201
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Vancomycin, a new antibiotic. I. Chemical and biologic properties.
Mh, M., Jm, M., PITTENGER, G. E., Pittenger, R. C., & Wm, S. (1955) · PubMed · Cited by 189
Ketolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
Shaw, K. J., Poppe, S., Schaadt, R., Brown-Driver, V., Finn, J., Pillar, C. M., Shinabarger, D., & Zurenko, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00859-08 · Cited by 181
SELVA, E., BERETTA, G., MONTANINI, N., SADDLER, G. S., GASTALDO, L., FERRARI, P., LORENZETTI, R., LANDINI, P., RIPAMONTI, F., GOLDSTEIN, B. P., et al. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.693 · Cited by 180
Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel
Kannan, K., Vázquez‐Laslop, N., & Mankin, A. S. (2012) · Cell · doi:10.1016/j.cell.2012.09.018 · Cited by 179
Thiopeptide Antibiotics: Retrospective and Recent Advances
Just-Baringo, X., Albericio, F., & Álvarez, M. (2014) · Marine Drugs · doi:10.3390/md12010317 · Cited by 179
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Willand, N., Dirié, B., Carette, X., Bifani, P., Singhal, A., Desroses, M., Leroux, F., Willery, E., Mathys, V., Déprez-Poulain, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1950 · Cited by 177
Resistance to antibiotics targeted to the bacterial cell wall
Nikolaidis, I., Favini‐Stabile, S., & Dessen, A. (2014) · Protein Science · doi:10.1002/pro.2414 · Cited by 176
Structural basis for selectivity and toxicity of ribosomal antibiotics
Böttger, E. C., Springer, B., Prammananan, T., Kidan, Y. G., & Sander, P. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve062 · Cited by 175
Mutations in the 16S rRNA Genes of Helicobacter pylori Mediate Resistance to Tetracycline
Trieber, C. A., & Taylor, D. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2131-2140.2002 · Cited by 174
Sum, P.-E., & Petersen, P. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173
In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline
Macone, A. B., Caruso, B. K., Leahy, R. G., Donatelli, J., Weir, S., Draper, M. P., Tanaka, S. K., & Levy, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-13 · Cited by 170
Engohang‐Ndong, J., Baillat, D., Aumercier, M., Bellefontaine, F., Besra, G. S., Locht, C., & Baulard, A. R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03809.x · Cited by 169
Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie · doi:10.1002/ange.200600350 · Cited by 169
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Blizzard, T. A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.-W., Ogawa, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.101 · Cited by 168
McComas, C. C., Crowley, B. M., & Boger, D. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja035901x · Cited by 166
Ribosomally Synthesized Thiopeptide Antibiotics Targeting Elongation Factor Tu
Morris, R. P., Leeds, J. A., Naegeli, H. U., Oberer, L., Memmert, K., Weber, E., LaMarche, M. J., Parker, C. N., Burrer, N., Esterow, S., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900488a · Cited by 166
Han, S., Zaniewski, R. P., Marr, E. S., Lacey, B. M., Tomaras, A. P., Evdokimov, A., Miller, J. R., & Shanmugasundaram, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013092107 · Cited by 166
Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants
Berisio, R., Harms, J., Schluenzen, F., Zarivach, R., Hansen, H. A. S., Fucini, P., & Yonath, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.14.4276-4279.2003 · Cited by 165
Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 164
Ribosome fidelity: tRNA discrimination, proofreading and induced fit
Rodnina, M. V., & Wintermeyer, W. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01737-0 · Cited by 164
Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
Draper, M. P., Weir, S., Macone, A., Donatelli, J., Trieber, C. A., Tanaka, S. K., & Levy, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01066-13 · Cited by 158
Zhanel, G. G., Sniezek, G., Schweizer, F., Zelenitsky, S. A., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2009) · Drugs · doi:10.2165/00003495-200969070-00003 · Cited by 151
The Ribosome through the Looking Glass
Wilson, D. N., & Nierhaus, K. H. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200544 · Cited by 147
Ceftaroline fosamil: a new broad-spectrum cephalosporin
Laudano, J. B. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr095 · Cited by 147
Reversible inhibitors of penicillinases
Kiener, P. A., & Waley, S. G. (1978) · Biochemical Journal · doi:10.1042/bj1690197 · Cited by 139
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · ChemInform · doi:10.1002/chin.200524271 · Cited by 138
Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli
Chittum, H. S., & Champney, W. S. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.20.6192-6198.1994 · Cited by 134
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
Ness, S. R., Martin, R., Kindler, A. M., Paetzel, M., Gold, M. H., Jensen, S. E., Jones, J. B., & Strynadka, N. C. J. (2000) · Biochemistry · doi:10.1021/bi992505b · Cited by 133
Aronoff, S. C., Jacobs, M. R., Johenning, S., & Yamabe, S. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.580 · Cited by 126
Sader, H. S., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01737-10 · Cited by 123
Smith, L. K., & Mankin, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-07 · Cited by 122
Ma, Z., Clark, R. F., Brazzale, A., Wang, S., Rupp, M., Li, L., Griesgraber, G. W., Zhang, S., Yong, H., Phan, L., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102349 · Cited by 120
Frénois, F., Engohang‐Ndong, J., Locht, C., Baulard, A. R., & Villeret, V. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.020 · Cited by 120
Redesign of Glycopeptide Antibiotics: Back to the Future
James, R. C., Pierce, J. G., Okano, A., Xie, J. H., & Boger, D. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300007j · Cited by 118
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
LaMarche, M. J., Leeds, J. A., Amaral, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201685h · Cited by 116
Telithromycin‐associated hepatotoxicity
Brinker, A. D., Wassel, R. T., Lyndly, J., Serrano, J., Avigan, M., Lee, W. M., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22620 · Cited by 116
Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs
Nitanai, Y., Kikuchi, T., Kakoi, K., Hanamaki, S., Fujisawa, I., & Aoki, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.026 · Cited by 115
Ross, D. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078032 · Cited by 115
Dover, L. G., Corsino, P. E., Daniels, I. R., Cocklin, S., Tatituri, V., Besra, G. S., & Fütterer, K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.003 · Cited by 111
How Should We Think About the Ribosome?
Moore, P. B. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-050511-102314 · Cited by 111
Lahiri, S. D., Mangani, S., Jahić, H., Benvenuti, M., Durand-Réville, T. F., Luca, F. D., Ehmann, D. E., Rossolini, G. M., Alm, R. A., & Docquier, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500703p · Cited by 109
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Or, Y. S., Clark, R. F., Wang, S., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990618n · Cited by 104
Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria
Savage, P. B. (2001) · Annals of Medicine · doi:10.3109/07853890109002073 · Cited by 96
New antibiotic that acts specifically on the GTP‐bound form of elongation factor Tu.
Anborgh, P. H., & Parmeggiani, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08009.x · Cited by 96
Flipo, M., Desroses, M., Lecat‐Guillet, N., Dirié, B., Carette, X., Leroux, F., Piveteau, C., Demirkaya, F., Lens, Z., Rucktooa, P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200076a · Cited by 95
Kishida, H., Unzai, S., Roper, D. I., Lloyd, A. J., Park, S., & Tame, J. R. H. (2005) · Biochemistry · doi:10.1021/bi051533t · Cited by 92
Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics
Fishovitz, J., Rojas-Altuve, A., Otero, L. H., Dawley, M. M., Carrasco‐López, C., Chang, M., Hermoso, J. A., & Mobashery, S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5030657 · Cited by 92
Zhanel, G. G., Lam, A., Schweizer, F., et al. (2008) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200809040-00004 · Cited by 91
Structure-based drug design meets the ribosome
Franceschi, F. J., & Duffy, E. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.026 · Cited by 91
Livermore, D. M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt118 · Cited by 90
Mankin, A. S. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.08.003 · Cited by 85
Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
Skripkin, E. A., McConnell, T., DeVito, J., Lawrence, L. E., Ippolito, J. A., Duffy, E. M., Sutcliffe, J. A., & Franceschi, F. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-07 · Cited by 80
McGuire, J. M., BUNCH, R. L., ANDERSON, R. C., Boaz, H. E., Flynn, E. H., POWELL, H. M., & SMITH, J. W. (1952) · PubMed · Cited by 79
Bertrand, D., Bertrand, S., Neveu, E., & FERNANDES, P. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-10 · Cited by 76
Struktur‐Wirkungs‐Beziehungen von Oxazolidinonen: Grundlage der Entwicklung von Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie · doi:10.1002/ange.200200528 · Cited by 76
In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
Lawrence, L. E., Danese, P. N., DeVito, J. A., Franceschi, F. J., & Sutcliffe, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01383-07 · Cited by 75
Low Fitness Cost of the Multidrug Resistance Gene cfr
LaMarre, J. M., Locke, J. B., Shaw, K. J., & Mankin, A. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-11 · Cited by 71
NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis
Xu, H., Hazra, S., & Blanchard, J. S. (2012) · Biochemistry · doi:10.1021/bi300508r · Cited by 70
New aminoglycoside antibiotics
Dozzo, P., & Moser, H. E. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.506189 · Cited by 69
Okano, A., Nakayama, A., Wu, K., Lindsey, E. A., Schammel, A. W., Feng, Y., Collins, K. C., & Boger, D. L. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01008 · Cited by 69
Micrococcin, an antibacterial substance formed by a strain of Micrococcus.
SU, T. L. (1948) · PubMed · Cited by 66
Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance
Pieren, M., & Tigges, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.005 · Cited by 64
Die Bekämpfung multiresistenter Bakterien: aktuelle Strategien zur Entdeckung neuer Antibiotika
O’Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie · doi:10.1002/ange.201209979 · Cited by 63
Russo, T. A., Page, M. G. P., Beanan, J. M., Olson, R., Hujer, A. M., Hujer, K. M., Jacobs, M. R., Bajaksouzian, S., Endimiani, A., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr013 · Cited by 63
Siderophore Receptor-Mediated Uptake of Lactivicin Analogues in Gram-Negative Bacteria
Starr, J. T., Brown, M. F., Aschenbrenner, L. M., Caspers, N. L., Che, Y., Gerstenberger, B. S., Huband, M. D., Knafels, J. D., Lemmon, M. M., Li, C., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500219c · Cited by 60
Thiostrepton, a new antibiotic. I. In vitro studies.
Donovick, R., Pagano, J. F., STOUT, H. A., & WEINSTEIN, M. J. (1955) · PubMed · Cited by 59
Church, R. F. R., Schaub, R. E., & Weiss, M. J. (1971) · The Journal of Organic Chemistry · doi:10.1021/jo00804a025 · Cited by 58
HYDROGENOLYSIS STUDIES IN THE TETRACYCLINE SERIES—6-DEOXYTETRACYCLINES
Stephens, C. R., Murai, K., Rennhard, H. H., Conover, L. H., & Brunings, K. J. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01552a082 · Cited by 57
Bacterial Ribosomal Subunit Assembly is an Antibiotic Target
Champney, W. S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452186 · Cited by 54
Lemaire, S., Fuda, C., Françoise Van Bambeke, A., Tulkens, P. M., & Mobashery, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800079200 · Cited by 52
Totir, M. A., Padayatti, P. S., Helfand, M. S., Carey, M. P., Bonomo, R. A., CAREY, P. R., & van den Akker, F. (2006) · Biochemistry · doi:10.1021/bi060990m · Cited by 51
L22 Ribosomal Protein and Effect of Its Mutation on Ribosome Resistance to Erythromycin
Davydova, N., Streltsov, V. A., Wilce, M. C. J., Liljas, A., & Garber, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00772-6 · Cited by 48
Zhou, J., Bhattacharjee, A., Chen, S., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.014 · Cited by 44
Zur Rolle der chemischen Synthese in der Entwicklung antibakterieller Wirkstoffe
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie · doi:10.1002/ange.201310843 · Cited by 43
LaMarche, M. J., Leeds, J. A., Amaral, K., Brewer, J. T., Bushell, S. M., Dewhurst, J. M., Dzink-Fox, J., Gangl, E. T., Goldovitz, J., Jain, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200938f · Cited by 41
McKinney, D. C., Zhou, F., Eyermann, C. J., Ferguson, A. D., Prince, D. B., Breen, J. N., GIACOBBE, R. A., Lahiri, S. D., & Verheijen, J. C. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00031 · Cited by 40
Höfer, B., Dantier, C., Gebhardt, K., Desarbre, E., Schmitt‐Hoffmann, A. H., & Page, M. G. P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks527 · Cited by 39
Discovery of novel antibacterials
Miller, J. R., & Waldrop, G. L. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903493449 · Cited by 38
Lanz, J., & Riedl, R. (2014) · ChemMedChem · doi:10.1002/cmdc.201402478 · Cited by 38
Self-citationStructure of sisomicin, a novel unsaturated aminoglycoside antibiotic from Micromonospora inyoensis
Cooper, D. J., Jaret, R. S., & Reimann, H. (1971) · Journal of the Chemical Society D Chemical Communications · doi:10.1039/c29710000285 · Cited by 38
Genomic Effects of Polyamide/DNA Interactions on mRNA Expression
Supeková, Ľ., Pezacki, J. P., Su, A. I., Loweth, C. J., Riedl, R., Geierstanger, B. H., Schultz, P. G., & Wemmer, D. E. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00174-6 · Cited by 34
Self-citationFrénois, F., Baulard, A. R., & Villeret, V. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.07.005 · Cited by 34
Murphy-Benenato, K. E., Dangel, B., Davis, H. E., Durand-Réville, T. F., Ferguson, A. D., Gao, N., Jahić, H., Mueller, J. P., Manyak, E. L., Quiroga, O., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00026 · Cited by 30
Murphy-Benenato, K. E., Bhagunde, P. R., Chen, A., Davis, H. E., Durand-Réville, T. F., Ehmann, D. E., Galullo, V., Harris, J. J., Hatoum‐Mokdad, H., Jahić, H., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501506f · Cited by 29
Krokidis, M. G., Marquez, V., Wilson, D. N., Kalpaxis, D. L., & Dinos, G. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01994-13 · Cited by 21
Fischer, T., & Riedl, R. (2013) · ChemMedChem · doi:10.1002/cmdc.201300278 · Cited by 19
Self-citationWilson, D. N., & Nierhaus, K. H. (2003) · Angewandte Chemie · doi:10.1002/ange.200200544 · Cited by 12
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Frieri, M., Kumar, K., & Boutin, A. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.08.007 · Cited by 1,100
Yin, W., Yu, J., Lv, F., Yan, L., Zheng, L. R., Gu, Z., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b05810 · Cited by 1,003
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Antibiotic‐Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives
Wang, Y., Yang, Y., Shi, Y., Song, H., & Yu, C. (2020) · Advanced Materials · doi:10.1002/adma.201904106 · Cited by 700
Metadata
- Authors
- Chellat, M. F., Raguž, L., & Riedl, R.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2016-03-22
- Volume
- 55
- Issue
- 23
- Pages
- 6600-6626
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2312102558
- Cited by
- 487
- References
- 177
- FWCI
- 20.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.